Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Development of a gel permeation chromatographic assay to achieve mass balance in cellulose acetate phthalate stability studies.

Mayhew JW, Gideon LT, Ericksen B, Hlavaty JJ, Yeh SM, Chavdarian CG, Strick N, Neurath AR.

J Pharm Biomed Anal. 2009 Feb 20;49(2):240-6. doi: 10.1016/j.jpba.2008.10.039. Epub 2008 Nov 5.

2.

Anti-HIV-1 activity of poly(mandelic acid) derivatives.

Ward M, Yu B, Wyatt V, Griffith J, Craft T, Neurath AR, Strick N, Li YY, Wertz DL, Pojman JA, Lowe AB.

Biomacromolecules. 2007 Nov;8(11):3308-16. Epub 2007 Oct 20.

PMID:
17949101
3.

Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.

Neurath AR, Strick N, Li YY.

BMC Infect Dis. 2006 Oct 16;6:150.

4.

Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.

Neurath AR, Strick N, Li YY, Debnath AK.

Ann N Y Acad Sci. 2005 Nov;1056:311-27. Review.

PMID:
16387698
5.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK.

Virology. 2005 Sep 1;339(2):213-25.

6.

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Fichorova RN, Zhou F, Ratnam V, Atanassova V, Jiang S, Strick N, Neurath AR.

Antimicrob Agents Chemother. 2005 Jan;49(1):323-35.

7.
8.

Water dispersible microbicidal cellulose acetate phthalate film.

Neurath AR, Strick N, Li YY.

BMC Infect Dis. 2003 Nov 14;3:27.

9.

Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.

Neurath AR, Strick N, Li YY.

BMC Infect Dis. 2002 Nov 21;2:27. Epub 2002 Nov 21.

10.
12.

Quantitation of cellulose acetate phthalate in biological fluids as a complex with ruthenium red.

Neurath AR, Strick N.

Anal Biochem. 2001 Jan 1;288(1):102-4. No abstract available.

PMID:
11141313
13.

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Neurath AR, Strick N, Li YY, Lin K, Jiang S.

Biologicals. 1999 Mar;27(1):11-21.

PMID:
10441398
14.

3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.

Neurath AR, Strick N, Li YY.

Antivir Chem Chemother. 1998 Mar;9(2):177-84.

PMID:
9875389
15.

Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro.

Seppälä M, Jiang S, Strick N, Lin K, Li YY, Koistinen H, Koistinen R, Neurath AR.

Lab Invest. 1997 Aug;77(2):127-30.

PMID:
9274854
16.

Chemically modified bovine beta-lactoglobulin blocks uptake of HIV-1 by colon- and cervix-derived epithelial cell lines.

Jiang S, Lin K, Strick N, Li YY, Neurath AR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):461-2. No abstract available.

PMID:
8970474
17.

A herpesvirus inhibitor from bovine whey.

Neurath AR, Li YY, Strick N, Jiang S.

Lancet. 1996 Jun 15;347(9016):1703-4. No abstract available.

PMID:
8643002
18.

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.

Neurath AR, Jiang S, Strick N, Lin K, Li YY, Debnath AK.

Nat Med. 1996 Feb;2(2):230-4.

PMID:
8574970
20.
21.

Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.

Neurath AR, Strick N, Lin K, Jiang S.

AIDS Res Hum Retroviruses. 1995 Jun;11(6):687-96.

PMID:
7576928
22.
24.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

Debnath AK, Jiang S, Strick N, Lin K, Haberfield P, Neurath AR.

J Med Chem. 1994 Apr 15;37(8):1099-108. Erratum in: J Med Chem 1994 Jun 10;37(12):1898.

PMID:
8164251
25.

Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.

Neurath AR, Strick N, Li YY, Jiang S.

AIDS Res Hum Retroviruses. 1993 Dec;9(12):1195-208.

PMID:
8142138
26.

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

Jiang S, Lin K, Strick N, Neurath AR.

Biochem Biophys Res Commun. 1993 Sep 15;195(2):533-8.

PMID:
8373393
27.

HIV-1 inhibition by a peptide.

Jiang S, Lin K, Strick N, Neurath AR.

Nature. 1993 Sep 9;365(6442):113. No abstract available.

PMID:
8371754
28.
29.
31.
32.

Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.

Neurath AR, Jiang S, Strick N, Kolbe H, Kieny MP, Muchmore E, Girard M.

AIDS Res Hum Retroviruses. 1991 Oct;7(10):813-23.

PMID:
1720628
34.

Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.

Neurath AR, Strick N, Fields R, Jiang S.

AIDS Res Hum Retroviruses. 1991 Aug;7(8):657-62.

PMID:
1718344
35.
36.

Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands.

Petit MA, Strick N, Dubanchet S, Capel F, Neurath AR.

Mol Immunol. 1991 Apr-May;28(4-5):517-21.

PMID:
1712075
37.

Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development.

Neurath AR, Strick N, Taylor P, Rubinstein P, Stevens CE.

AIDS Res Hum Retroviruses. 1990 Oct;6(10):1183-92.

PMID:
1701315
38.
39.

Detection of receptors for hepatitis B virus on cells of extrahepatic origin.

Neurath AR, Strick N, Sproul P, Ralph HE, Valinsky J.

Virology. 1990 Jun;176(2):448-57.

PMID:
2161145
42.
44.

Advances in understanding structure-function relationships in hepatitis B virus (HBV) envelope (ENV) proteins.

Neurath AR, Strick N.

Adv Exp Med Biol. 1989;251:237-50. Review. No abstract available.

PMID:
2481963
45.
46.
48.

Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.

Neurath AR, Kent SB, Strick N, Parker K, Courouce AM, Riottot MM, Petit MA, Budkowska A, Girard M, Pillot J.

Mol Immunol. 1987 Sep;24(9):975-80.

PMID:
3657811
49.

Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.

Neurath AR, Kent SB, Adamowicz P, Riottot MM, Price P, Strick N, Parker K, Petit MA, Budkowska A, Girard M, et al.

Mol Immunol. 1987 Jun;24(6):561-8.

PMID:
3657796
50.

Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein.

Neurath AR, Adamowicz P, Kent SB, Riottot MM, Strick N, Parker K, Offensperger W, Petit MA, Wahl S, Budkowska A, et al.

Mol Immunol. 1986 Sep;23(9):991-7.

PMID:
2431299

Supplemental Content

Loading ...
Support Center